Qosina has announced the appointment of David Oh as the new representative for the Korean market.

David brings over two decades of invaluable experience to his new role, having been actively involved in the medical device industry since graduating from Penn State University in 2000. With a solid foundation in market analysis and sales forecasting, he has a proven track record of driving business growth and implementing effective sales strategies.

One of David’s notable strengths lies in his ability to navigate regulatory matters, particularly with the Ministry of Food and Drug Safety (MFDS). His experience in developing policies to handle regulatory affairs will help the Qosina customer move towards compliance with standards and regulations. David is also well-versed in developing quality control strategies essential for maintaining MFDS approvals and advising customers on the requirements set forth by the Korea Medical Device Industry Association (KMDIA).

David’s extensive experience and expertise make him an invaluable asset to us as Qosina continues to expand in the Korean market. We are confident that David will provide unparalleled support and solutions in Korea,” said Jeff Cushner, Vice President of Sales at Qosina, a leading global supplier of over 5,000 OEM single-use components to the medical and biopharmaceutical industries.

en_GBEnglish (UK)